School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland.
Chapman University School of Pharmacy, Irvine, CA, USA.
Travel Med Infect Dis. 2024 Sep-Oct;61:102758. doi: 10.1016/j.tmaid.2024.102758. Epub 2024 Aug 30.
The increasing prevalence of falsified and counterfeit medicines globally poses risks to international travellers. This narrative literature review examines the global challenge of falsified and counterfeit medicines, with a specific focus on risks for travellers. The aim is to provide a comprehensive understanding of this multidimensional issue, exploring potential solutions for effective intervention.
A comprehensive search of databases, including PubMed, MEDLINE, and Scopus, as well as relevant reports from international organisations, was undertaken. There was a focus on extracting information pertaining to the prevalence, types, and geographical patterns of falsified and counterfeit medicines encountered by international travellers. Synthesising this information helped to identify overarching trends and patterns. This narrative review utilised a thematic analysis approach to synthesise the findings.
The findings revealed a diverse range of counterfeit drug categories, spanning from antibiotics to lifestyle medications, posing unique risks to travellers navigating the global pharmaceutical landscape. The review emphasises the geographical distribution of these drugs, with varying consequences for both high- and low-income nations. The inadequate formulations and inconsistent drug release arising from these practices pose severe threats to public health, especially for individuals travelling abroad. The review also highlights the significance of international collaboration in addressing this global challenge, as pharmaceutical supply chains seamlessly cross borders, necessitating a collaborative approach for effective regulation and enforcement.
This review underscores the need for targeted research, collaborative interventions, and technological innovations to address the complexities associated with falsified and counterfeit medicines, ensuring the safety and well-being of international travellers.
全球假药和伪劣药品的日益泛滥给国际旅行者带来了风险。本叙事性文献综述考察了假药和伪劣药品的全球挑战,特别关注了旅行者面临的风险。目的是全面了解这一多维度问题,探索有效干预的潜在解决方案。
对包括 PubMed、MEDLINE 和 Scopus 在内的数据库以及国际组织的相关报告进行了全面搜索。重点是提取有关国际旅行者遇到的假药和伪劣药品的流行率、类型和地理模式的信息。综合这些信息有助于识别总体趋势和模式。本叙事性综述采用主题分析方法对研究结果进行综合。
研究结果揭示了各种假冒药品类别,从抗生素到生活方式用药都有涉及,这些药品给在全球药品市场中穿梭的旅行者带来了独特的风险。综述强调了这些药品的地理分布,对高收入和低收入国家都有不同的影响。这些做法导致的不适当配方和药物释放不一致对公众健康构成了严重威胁,特别是对出国旅行的人。综述还强调了国际合作在应对这一全球挑战中的重要性,因为药品供应链无缝跨越国界,需要采取协作方法进行有效监管和执法。
本综述强调了需要进行有针对性的研究、协作干预和技术创新,以应对假药和伪劣药品相关的复杂性,确保国际旅行者的安全和健康。